MedTrace Logo

Bioarray for the Serological Assessment of Immunity Against Vaccine-preventable Infections

NCT03107312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2017-05-15

No results posted yet for this study

Summary

Recent observations in Germany revealed above-average high proportions of refugees affected by infectious diseases of public health significance. Scrutiny of the vaccination status showed sizeable presence of seronegative subjects, with conspicuously higher prevalence among children and adolescents, thus indicating urgent necessity of i) rapid identification of carriers of vaccine-preventable diseases and ii) adjustment of protection against such infections to European Standards. Rapid immune status check needs comprehensive diagnostic tool permitting simultaneous assessment of seropositivity. Validation of such tools requires comparisons of the immune status of subjects with known vaccination history with that of migrants with incomplete or missing health and vaccination records.

Conditions

  • Immunization; Infection

Interventions

PROCEDURE

Single blood sample collection

Collection of single blood sample of 10 ml volume by venepuncture

Sponsors & Collaborators

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Mathias Pletz, M.D. · Center for Infectious Diseases and Infection Control

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107312 on ClinicalTrials.gov